Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

Hong Kong · Delayed Price · Currency is HKD

0.1450

0.00 (0.00%)

Jul 31, 2026, 2:49 PM HKT

HKG:8189 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	522.97	522.97	385.48	398	403.73	476.38
Revenue Growth	33.10%	35.67%	-3.15%	-1.42%	-15.25%	28.98%
Gross Profit	-29.4	-29.4	16.97	21.37	14.82	45.6
Operating Income	-67.68	-67.68	-28.38	-19.34	-24.41	-18.39
Net Income	-90.82	-90.82	-27.8	-20.16	-27.45	-42.26
Earnings Per Share	-0.04	-0.04	-0.01	-0.01	-0.01	-0.02
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Fertiliser Products	413.41	413.41	384.85	397.42	403.18	475.65
Elderly Care and Health Care Services	109.56	109.56	0.64	0.57	0.55	0.74
Total	522.97	522.97	385.48	398	403.73	476.38

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	29.21	29.21	25.4	5.93	7.21	27.44
Total Debt	109.74	109.74	162.12	85.76	102.61	90.34
Net Cash (Debt)	-80.53	-80.53	-136.72	-79.83	-95.4	-62.9
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.04	-0.04	-0.07	-0.04	-0.05	-0.03

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-54.58	-54.58	-26.27	-13.15	-12.82	-6.68
Capital Expenditures	-8.26	-8.26	-2.56	-2.47	-8.8	-27.6
Free Cash Flow	-62.84	-62.84	-28.83	-15.62	-21.62	-34.28
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-5.62%	-5.62%	4.40%	5.37%	3.67%	9.57%
Operating Margin	-12.94%	-12.94%	-7.36%	-4.86%	-6.05%	-3.86%
Pretax Margin	-21.60%	-21.60%	-9.91%	-3.02%	-5.96%	-9.41%
Profit Margin	-17.37%	-17.37%	-7.21%	-5.07%	-6.80%	-8.87%
FCF Margin	-12.02%	-12.02%	-7.48%	-3.92%	-5.36%	-7.20%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	0.53	1.12	1.50	0.39	0.83	0.55